Dormond O - Search Results

1

Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone-Dependent Release of Circulating Tumor DNA.

Labgaa I, von Felden J, Craig AJ, Martins-Filho SN, Villacorta-Martin C, Demartines N, Dormond O, D'Avola D, Villanueva A. Labgaa I, et al. Among authors: dormond o. Hepatol Commun. 2021 Mar 23;5(6):1095-1105. doi: 10.1002/hep4.1692. eCollection 2021 Jun. Hepatol Commun. 2021. PMID: 34141992 Free PMC article.

2

The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication.

Labgaa I, Villanueva A, Dormond O, Demartines N, Melloul E. Labgaa I, et al. Among authors: dormond o. Cancers (Basel). 2021 Feb 6;13(4):659. doi: 10.3390/cancers13040659. Cancers (Basel). 2021. PMID: 33562173 Free PMC article. Review.

3

Basic Science with Preclinical Models to Investigate and Develop Liquid Biopsy: What Are the Available Data and Is It a Fruitful Approach?

Cena B, Melloul E, Demartines N, Dormond O, Labgaa I. Cena B, et al. Among authors: dormond o. Int J Mol Sci. 2022 May 10;23(10):5343. doi: 10.3390/ijms23105343. Int J Mol Sci. 2022. PMID: 35628154 Free PMC article. Review.

4

Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?

Gonvers S, Tabrizian P, Melloul E, Dormond O, Schwartz M, Demartines N, Labgaa I. Gonvers S, et al. Among authors: dormond o. Front Oncol. 2022 Aug 11;12:940473. doi: 10.3389/fonc.2022.940473. eCollection 2022. Front Oncol. 2022. PMID: 36033451 Free PMC article. Review.

5

Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives.

Faes S, Demartines N, Dormond O. Faes S, et al. Among authors: dormond o. Front Cell Dev Biol. 2021 Mar 15;9:636037. doi: 10.3389/fcell.2021.636037. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33791295 Free PMC article. Review.

6

Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity.

Faes S, Demartines N, Dormond O. Faes S, et al. Among authors: dormond o. Oxid Med Cell Longev. 2017;2017:1726078. doi: 10.1155/2017/1726078. Epub 2017 Feb 9. Oxid Med Cell Longev. 2017. PMID: 28280521 Free PMC article. Review.

7

Reactivation of AKT signaling following treatment of cancer cells with PI3K inhibitors attenuates their antitumor effects.

Dufour M, Dormond-Meuwly A, Pythoud C, Demartines N, Dormond O. Dufour M, et al. Among authors: dormond meuwly a, dormond o. Biochem Biophys Res Commun. 2013 Aug 16;438(1):32-7. doi: 10.1016/j.bbrc.2013.07.014. Epub 2013 Jul 15. Biochem Biophys Res Commun. 2013. PMID: 23867821

8

ATP-competitive inhibitors of mTOR: new perspectives in the treatment of renal cell carcinoma.

Roulin D, Demartines N, Dormond O. Roulin D, et al. Among authors: dormond o. Biochem Soc Trans. 2011 Apr;39(2):492-4. doi: 10.1042/BST0390492. Biochem Soc Trans. 2011. PMID: 21428926 Review.

9

Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo.

Roulin D, Cerantola Y, Dormond-Meuwly A, Demartines N, Dormond O. Roulin D, et al. Among authors: dormond meuwly a, dormond o. Mol Cancer. 2010 Mar 12;9:57. doi: 10.1186/1476-4598-9-57. Mol Cancer. 2010. PMID: 20226010 Free PMC article.

10

Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies.

Faes S, Uldry E, Planche A, Santoro T, Pythoud C, Demartines N, Dormond O. Faes S, et al. Among authors: dormond o. Oncotarget. 2016 Dec 27;7(52):86026-86038. doi: 10.18632/oncotarget.13323. Oncotarget. 2016. PMID: 27852069 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters